User:SheridanFord/sandbox

Rowshan Reordan

Rowshan Reordan, J.D., a licensed attorney, is the founder and CEO of Green Leaf Lab LLC. Founded in 2011, as the first accredited, woman-owned cannabis and hemp CBD analytical testing laboratory in the United States certified Women Business Enterprise National Council (WBENC). Rowshan was among the early innovators in the cannabis sector. In 2021 and 2022, her company was listed as one of the Top 50 Most Trustworthy Companies. Recognized as a leader in the standardization of chemical lab testing of cannabis and CBD, Reordan runs certified testing labs in the states of Oregon (OLCC License 010-10029074C70) and California (C8-0000078-LIC). Green Leaf Lab is one of the leading companies in independent third-party analytical cannabis testing.

Background

Rowshan earned her way through higher education, earning a Juris Doctorate from the University of New Mexico School of Law. She also holds a Master's degree in political science with a focus on human rights. She combined her legal background with a deep commitment to product safefy and quality control in the cannabis community as an entrepreneur committed to corporate social responsibility.

Her foray into testing medical and recreational cannabis was sparked by the struggles of a close friend living with HIV, who often used medical cannabis. Their demise to the disease led her to wonder if these products were safe and uncontaminated. In those days, there were no state or federal regulations in place to ensure the safety of cannabis as a consumed product. Reordan saw Colorado and Washington legalize recreational cannabis without product safety testing standards, leading her to open a lab in Oregon in 2011.The absence of reliable testing for pesticides and mold in cannabis was a glaring gap. Founding the first woman-owned analytical cannabis testing laboratory in the nation was a milestone in her career and in the industry.

As a cannabis activist, Reordan fought misinformation and medical testing injustice to provide safe and healthy products to consumers of cannabis, which has become the "top cash crop, in states where it is legal," worth more than potatoes or rice the U.S., and recreational marijuana was the nation's "6th most valuable cash crop" in 2022. Oregon's monthly sales averaged $99 million during the pandemic boom. Sales dipped in 2021 due to a predictable market correction.

Innovation and Advocacy

Green Leaf Lab trademarked their "Cannalysis" process of analytic cannabis testing and employed trained chemists using standardized and peer reviewed analytic testing equipment to set new industry standards.

In 2019, Green Leaf Lab filed a complaint ending in a legal battle that centered around the critical need to protect proprietary lab procedures and transparency in the emergent cannabis industry's regulatory standards, for which Reordan has been a leader. Her work in analytical chemical testing of cannabis potency and accusations of impropriety were dismissed in U.S. California Central District Court. (see thumbnail for Order to Dismiss with Prejudice).

In 2013, she was invited to join a subcommittee on testing medical marijuana for Oregon's House Bill 3460. She was a staunch advocate for safe testing of medical and recreational cannabis not only in Oregon but throughout the nation. In 2015. Reordan gave a statement before the Oregon Legislature outlining eight product safety and public health recommendations to better regulate the cannabis industry:

1. Laboratories should have regulatory oversight. This will ensure a system where there is accountability and standardization for the safety testing of cannabis.
2. Independent Third-Party Testing should be required. ... It is in the best interest of Oregon patients and consumers to have an Oregon-based regulatory agency that follows national quality standards that are known to be more stringent than international standards.
3. Laboratories should be required to perform random sampling and initiate a chain of custody system for batch testing certification.
4. More stringent microbiological (mold) testing should be required. The current law requires general screening for molds. This screening process does not require identification of harmful molds (for instance, Aspergillus, of which certain species can produce toxins). The current system allows harmful molds to “pass” if the overall screen falls below 10,000 colony forming units per gram. We believe that requiring a more specific microbiological screen for harmful molds will promote public health and safety.
5. More specific pesticide testing should be required.
6. Residual solvent testing should be required.
7. Standardized methods for potency testing should be required. ... [to] support a system that patients and consumers can trust.
8. Laboratory and testing standards should protect public health, while taking into consideration affordable testing and the legitimization of the cannabis industry. Because cannabis testing is in its infancy, there are many theories regarding the best way to analyze cannabis for safe use.

Hiphop WikiEdu Sp 2023

Now, here's what we will do during our edit-a-thon

Start ZOOM screen share.

NOTE: LET THE ENVIRONMENT (the interface, dashboard, and talk pages) DO THE HEAVY LIFTING

1. The outcome of the edit-a-thon: YOU'LL MAKE YOUR FIRST EDITS. Make 10 small edits and become an auto-confirmed user: you'll be a Wikipedian.
   1. Explain What, Why, and How. AIM: for 85% of those present make at least one simple edit (wikilink).
   2. What is an edit-a-thon? Watch Afro-Crowd's Edit-a-Thon video
2. 2 mins: Students read the Wikipedia Channel post aloud in their groups
3. SIGN-IN ON YOUR DEVICE: In your group, make sure those have yet to sign up for WP and joined the WikiEdu.org dashboard do that now.
   1. If you haven't completed the training, spend 20 mins before we leave start and sense how easy or hard it will be to complete.
   2. Would it be possible to complete your training for next week's assignment? Write about what you learned editing.
4. Let's tour the WikiEdu Dashboard: https://dashboard.wikiedu.org/courses/University_at_Albany_SUNY/HipHop_Music_Culture_(Spring_2023)
5. Get started editing: AfroCrowd Tutorial video playlist https://youtu.be/nq0heoghu5E
   1. We will learn our way around the basics of a WP article https://youtu.be/lmiuxbGeZt8
   2. DOING EDITS: Study the intro of an article and then add crosslinks aka WikiLinks to link other articles so the intro to the article makes deeper sense with the hoover preview of key words. >> Let's study and add Wikilinks to: Grandmaster Flash on the Wheels of Steel >> There is no page for Cindy Campbell. Is she notable? Do a Google search for "Cindy Campbell and hip hop" and put those resources the Collab Library as citation with a link.
      1. Here's a page to cite about Campbell from City Lore: The New York Center for Urban Culture, founded in 1986 in LES. It's the first organization in the US devoted expressly to the "documentation, preservation, and presentation of urban folk culture: https://citylore.org/wp-content/uploads/2022/01/Cindy-Campbell-page.pdf
      2. Another source: https://www.smithsonianmag.com/smithsonian-institution/how-the-block-party-became-an-urban-phenomenon-180980560/#:~:text=On%20the%20night%20of%20August,the%20West%20Bronx%2C%20New%20York.
      3. You could add a link from reading the Smithsonian on women in hiphop. Links help avoid orphan or walled off information or articles: https://nmaahc.si.edu/explore/stories/women-hip-hop
      4. You could find other sources to cite or paraphrase from JSTOR: https://daily.jstor.org/tag/hip-hop/

WHAT WILL WE EDIT?

Go to Dashboard and select a song to edit today:https://dashboard.wikiedu.org/courses/University_at_Albany_SUNY/HipHop_Music_Culture_(Spring_2023)/articles/assigned

The selected articles for our Feb 28th Edit-a-thon with AfroCrowd includes some of Rolling Stone's 100 Greatest Hip-Hop Songs of All Time from June of 2017 and selections from 60 Essential Songs by Women in HipHop in XXL Mag from March of 2020 (just as COVID-19 shut things down).

WHY?

As we celebrate the 50th anniversary, students will immerse themselves in the sounds of the most important and popular songs from both lists (Rolling Stone and XXL) and study them from a socio-cultural standpoint of gendered musical blackness. What story does the music tell when we include women? And what stories are Wikipedia pages telling about the gender continuum in hip-hop in 2023?

GENDER BIAS

For example, take a look at the talk page of West Coast hip hop article. I left a few notes for you all to both learn how talk pages work and to direct you towards the kind of feminist knowledge activism we will accomplish for our final presentations at the April 23 showcase in the lecture center. Students will create a pop-up exhibit of a gender-inclusive and gender-transformative music culture in honor of the 50th Anniversary of Hip Hop.

CHECK YOUR CONTRIBUTIONS on dashboard or on WP proper

Take a look at my contributions page to see my edits from past few days:

• 08:23, 28 February 2023 diff hist  +301‎  Talk:The Coup ‎ Red Link won't work so I added a note on talk page to share her notability current Tag: 2017 wikitext editor
• 08:20, 28 February 2023 diff hist  −4‎  The Coup ‎ Undid revision 1142093412 by SheridanFord (talk) current Tag: Undo
• 08:19, 28 February 2023 diff hist  +4‎  The Coup ‎ Added wikilink Tags: Reverted Visual edit
• 08:16, 28 February 2023 diff hist  +452‎  Talk:10% Dis ‎ →‎This needs building out: new section current Tag: New topic
• 07:50, 28 February 2023 diff hist  +4‎  Sally Walker (song) ‎ Added red link for British game song that has plenty of sources online and in databases current Tag: Visual edit

• 00:35, 28 February 2023 diff hist  +254‎  Talk:The Low End Theory ‎ Added a task for my WikiEdu course current Tag: 2017 wikitext editor

27 February 2023

• 23:52, 27 February 2023 diff hist  +435‎  Talk:Sarah Jones (stage actress) ‎ Request for task current Tag: 2017 wikitext editor
• 19:15, 27 February 2023 diff hist  +401‎  Talk:West Coast hip hop ‎ Added tasks for gender parity current Tag: 2017 wikitext editor
• 19:12, 27 February 2023 diff hist  +874‎  Talk:Uprock ‎ →‎Prof. G's WikiEdu course on hip-hop suggested tasks: new section current Tag: New topic
• 19:09, 27 February 2023 diff hist  +235‎  Talk:Universal Zulu Nation ‎ Tasks for my WikiEdu course in Hip hop

Women in Cannabis

Women have been active in the cannabis industry, cannabis legalization, cannabis testing, and cannabis rights since the earliest days of commercialization, but they have also faced gendered obstacles impeding their growth in an industry worth over 12 million dollars since 2019. "The American cannabis industry accounted for $10 billion of 2018’s [global] figures, with the average U.S. dispensary pulling in $3 million a year."

Women took the helm in new businesses and markets as recreational cannabis was legalized particularly in four states—Alaska, Colorado, Oregon and Washington—from 2012 to 2014. Female executives and business owners in the budding market contribute to one of the biggest cash crop industries in the US as of 2022. In 2015, one report found that women were 36% of cannabis executives, which was an outstanding figure for a new industry. Four years later, one report indicated that just 17% of executives were women. Although women-owned cannabis businesses were reportedly making about three times as much as male-led businesses, raising capital tended to favor the latter. Gender bias has been a significant factor in policy decisions and organizational success due to anecdotal research showing an increase in women's  influence on the cannabis market.

Consumers of cannabis are increasing in Massachusetts, for instance, yet only 4.7% of cannabis businesses are owned by women in the state of Massachusetts compared to 19.3% of businesses in other industries.

According to some sources, the cannabis industry is a particularly woman-friendly environment and has a higher percentage of women than many other industries for several reasons. Cited reasons include its founding by "liberally minded rebels" less bound by gender conformity; and its being relatively new and "unhampered by established business networks" closed to women, and the lack of glass ceilings in some parts of the industry, especially "support" activities such as finance and investment, marketing, delivery, and agronomy research. Women comprised over 60% of executives in cannabis product testing laboratories in 2015, the highest rate of women executives in the cannabis industry. According to data analysis expert Giadha DeCarcer, "The cannabis industry is so new that there are very few barriers to get in, especially for women [entrepreneurs]".

Leadership in product testing and consumer safety

Several women have played pioneering roles in analytical chemistry and microbiology labs focused on cannabis and hemp product testing and consumer safety. Given the fast-pace of the commercial recreational marijuana sector since 2012, testing cannabis crops was not well regulated by any governmental entity.

Rowshan Reordan, a licensed attorney in the state of Oregon since 2006, was among the early innovators in the sector. In 2011, Reordan opened Oregon's Green Leaf Lab LLC, the first accredited, woman-owned, and nearly all women run cannabis and hemp testing laboratory in the United States. After questioning whether a close friend, who later lost a battle with HIV, had access to clean, tested cannabis, the founder and CEO went on to open a second accredited cannabis and hemp analytical laboratories in California. Green Leaf Lab obtained the original trademark for "CANNALYSIS," a process of analytic cannabis testing that employed trained chemists using standardized and peer reviewed analytic testing equipment in 2011. Since 2020, a high profile California testing lab has owned the trademark

Green Leaf Lab filed a legal complaint in 2019 which ended in a legal settlement. The legal case challenged the need to protect proprietary lab procedures and issues of secrecy vs. transparency given the lack of regulatory standards in analytical chemical testing of recreational cannabis potency.

In 2013, she had joined a subcommittee on testing medical marijuana for Oregon's House Bill 3460. Green Leaf Lab was a strong advocate for safe testing of medical and recreational cannabis in the U.S. In 2015. Reordan gave a statement before the Oregon Legislature outlining eight product safety and public health recommendations to better regulate the cannabis industry:

1. Laboratories should have regulatory oversight. This will ensure a system where there is accountability and standardization for the safety testing of cannabis.
2. Independent Third-Party Testing should be required. ... It is in the best interest of Oregon patients and consumers to have an Oregon-based regulatory agency that follows national quality standards that are known to be more stringent than international standards.
3. Laboratories should be required to perform random sampling and initiate a chain of custody system for batch testing certification.
4. More stringent microbiological (mold) testing should be required. More stringent microbiological (mold) testing should be required. The current law requires general screening for molds. This screening process does not require identification of harmful molds (for instance, Aspergillus, of which certain species can produce toxins). The current system allows harmful molds to “pass” if the overall screen falls below 10,000 colony forming units per gram. We believe that requiring a more specific microbiological screen for harmful molds will promote public health and safety.
5. More specific pesticide testing should be required.
6. Residual solvent testing should be required.
7. Standardized methods for potency testing should be required. ... [to] support a system that patients and consumers can trust.
8. Laboratory and testing standards should protect public health, while taking into consideration affordable testing and the legitimization of the cannabis industry. Because cannabis testing is in its infancy, there are many theories regarding the best way to analyze cannabis for safe use.

Another leader, Larisa Bolivar, has been a changemaker and advocate for consumer rights in cannabis. For two decades, she has been an advocate for social equity and justice as the executive director of the Cannabis Consumer Coalition whose activism has brought attention to patient and caregiver rights since the shift from legalizing medical marijuana to the rise of recreational marijuana. In a 2022 interview Bolivar was lauded for discovering the "first list of offending" growers in Colorado after "health officials started flagging commercial weed for dangerous pesticides in 2015." In the same interview, she called attention to gender inequities that appear to be linked to "wealthy white men" crowding out emergent markets with little concern for clean cannabis and hemp. "We still have a lot of messes to clean in Colorado cannabis and hemp," she said, "and right now social equity is a big one."

Other early women advocates of clean cannabis and analytical testing have included Dr. Michelle Sexton, a naturopathic doctor and clinician specializing in botanical medicine and cannabinoid pharmacology as Chief Officer of Phytalab in Washington State, Bethany Sherman, owner of a prominent cannabis lab (who was later forced out of her position due to racist behavior), and Camille Holiday.

Sexton was a former research scientist at Bastyr University who later worked at the Center for Cannabis and Social Policy, a 501(c)(3) non-profit public charity founded in 2013. The Center is an advocate for a drug war-free world where "social control rather than public safety" is the priority.[1] Sexton was the editor and technical advisor for the state of Washington's official guide for cannabis quality control. Discussing the obstacles in scientific marijuana research, Sexton's personal view was that obtaining funding was a far more significant barrier than gender discrimination for women in the field.

While women have been able to get in on the ground floor as scientists and owners of testing labs despite hostilities towards woman, gender inequalities in obtaining funding is also an issue leading to supportive affinity groups such as the for-profit networking group Women Grow in Denver, Colorado founded in 2014 by Jane West. Women Grow welcomes "canna-curious" to cannabis professional women, as well as men.

Women continue to play important roles in scientists, attorneys, business leaders, rights advocates, creatives in cooking, filmmaking, and writing, in governance, and in journalism.

Product Safety in the Cannabis Industry

From 2016 to 2020, job growth in the legal cannabis industry grew at faster than any other industry according to an independent provider of cannabis products that claims to serve more than 125 million consumers. In its fourth annual state-by-state job count of full-time job equivalents, Leafly.com reported that the industry was one of the "single greatest job creation engines...supporting 243,700 full-time-equivalent jobs as of early 2020" with a 15% annual increase totaling $10.73 billion dollars. With increased demand for medical and recreational marijuana and hemp use following the decriminalization of possession, distribution, and cultivation of cannabis that vary by state and country, "pseudo-chemists or lab technicians without formal training" bypass standards of occupational safety and health in the production of cannabis substances and consumer products.

Safety data sheets and other standardized public health protections in product safety testing often lag the entrepreneurial "gold rush" into a new market. Consumer interests in the therapeutic use of cannabis sativa plants may mislead consumers to trust products simply because of their legalization. Hemp and marijuana are genetically distinct forms of the cannabis sativa but differ based on their chemical composition, cultivation, and use. Marijuana remains an illegal psychotropic drug in most U.S. states, while hemp has a more industrial use in the production of manufactured and industrial goods including foods and beverages, personal care products, nutritional supplements, fabrics, textiles, and construction materials.

While laboratory testing of products should be matters of significant importance to the health of conscious consumers, the product safety sector of the industry is currently unregulated at a federal level in the U.S. and other countries. Women have been leading entrepreneurs in the laboratory testing space of the cannabis industry yet they often go unrecognized and suffer from aspects of workplace harassment and discrimination. Green Leaf Lab, the nation’s first woman-owned independent analytic cannabis and hemp CBD laboratory, was the first to be accredited and licensed by a state agency, setting the standard high in cannabis and hemp testing for over a decade in the states of Oregon and California.

Cannabis legalization and consumer safety

All forms of cannabis were listed as an illegal substance under the Controlled Substance Act (CSA) of 1970, unless they had a permit from the Drug Enforcement Agency (DEA). The Agriculture Improvement Act of 2018 (2018 Farm Bill) removed hemp from the definition of marijuana in the CSA. Cannabis plants and derivatives with 0.3% or less of the chemical delta-9-tetrahydrocannabinol (THC) on a dry weight basis or less are not considered controlled substances. Although hemp is no longer defined as a controlled substance under the CSA, FDA-regulated hemp products must meet the requirements of the Federal Food, Drug, and Cosmetic (FD&C) Act.

Cannabidiol (CBD) is a naturally occurring cannabinoid found in cannabis plants. CBD has been demonstrated as an effective treatment of epilepsy and treatment of seizures associated with Lennox‑Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in people one year of age and older with the product Epidiolex®. CBD showed no dependence potential in the clinical trials and may be a useful treatment for a number of other medical conditions.

With the medicinal, recreational, and industrial uses of cannabis comes risks to the consumer market. Some companies have sold CBD based products online with claims of health benefits proven to be unsubstantiated and unsanctioned by regulatory agencies for medical use. Medicinal products to treat various diseases and symptoms, personal care products (e.g., lotions, oils, shampoos, and cosmetics), food, and drinks are being manufactured and distributed without FDA oversight and often with unverified contents.

The U.S. The Food and Drug Administration has issued warning letters to manufacturers for fraudulent medical and production claims  specified concentrations of CBD when testing demonstrates the absence of CBD. The Federal Trade Commission is a regulatory agency responsible for protecting consumers from faulty and deceptive products, especially from advertisements made online and on social media platforms. The FTC investigated six companies under a task force nicknamed “Operation CBDeceit.'' The FTC claims that these companies made unverifiable claims that CBD can treat illnesses ranging from heart disease and cancer to Alzheimer’s and bipolar disorder.

Although some companies sold CBD products under false health outcome claims, physicians are using cannabis products to treat patients with serious diseases. In clinical trials, adverse impacts included effects as a result of the CBD interaction with the patient's current medications and liver injury from the drug Epidiolex, risks that are identified in the labeling of the drug.  

Legal use and regulation

As of 2021, cannabis is illegal for recreational use in the United States on the federal level. However, 14 states have legalized the recreational use of cannabis and an additional 13 states allow the use of “low THC, high CBD (cannabidiol)” cannabis for medical reasons.

Since 2019, 33 states, Puerto Rico, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands have created medical marijuana programs.

States fully legalizing cannabis	States approving medical use
Alaska, Arizona, California, Colorado, Illinois, Maine, Massachusetts, Michigan, Montana, Nevada,New Jersey, New York, Oregon, Vermont, Washington	Arkansas, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Minnesota, Mississippi, Missouri, New Hampshire, New Mexico, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, Virginia, West Virginia

The FDA is responsible for the regulation of any product that functions as a drug and medical products from cannabis fall under the category. Under the FD&C Act, products generated for therapeutic or medical use that change the structure or function of the body of humans or animals is a drug. As of 2021, the FDA approved three drugs produced from cannabis: Epidiolex, Marinol and Syndros for the treatment of seizures and anorexia from diseases such as Lennox-Gastaut syndrome, Dravet syndrome, tuberous sclerosis, and AIDS. Cesamet, made from the active ingredient nabilone, a chemical with a similar chemical structure to THC, also has been FDA approved.

Is Cannabidiol use safe?

Side effects of CBD include nausea, fatigue and irritability. CBD can increase the level in your blood of the blood thinner coumadin, and it can raise levels of certain other medications in your blood by the exact same mechanism that grapefruit juice does. A significant safety concern with CBD is that it is primarily marketed and sold as a supplement, not a medication. Currently, the FDA does not regulate the safety and purity of dietary supplements. So you cannot know for sure that the product you buy has active ingredients at the dose listed on the label. In addition, the product may contain other (unknown) elements. We also don’t know the most effective therapeutic dose of CBD for any particular medical condition.

1. https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476#:~:text=Is%20cannabidiol%20safe%3F,mechanism%20that%20grapefruit%20juice%20does.

Cannabis Testing and Laboratories

States that permit medical and recreational marijuana set their programs covering the regulations and requirements for growers, processors, retailers and laboratories. The United States, Canada, and Mexico generally test for potential contaminants such as pesticides, mycotoxins, microbiological pathogens, gross contaminants, and heavy metals, but testing of contaminants vary from state to state.

Each state has its own accreditation for their testing. California was the first state to decriminalize medical marijuana and, thus, the first to implement measures for cannabis safety testing. The State of California requires mandatory testing of all legal cannabis for more than 100 contaminants, including pesticides, fungi, mold, bacteria, mycotoxins, and heavy metals.

Cannabis also have to be tested for potency measured by the concentrations of the differing cannabinoids. Colorado performs testing for residual solvents, microbial contaminants, heavy metals, and pesticide residues, potency, and homogeneity tests for retail cannabis products. Some concentrated cannabis products involve extraction using solvents that are considered dangerous and even carcinogenic. Therefore testing protocols of cannabis labs include testing of residual solvents.

Supercritical carbon dioxide is a common solvent used because they evaporate at regular temperature and pressure and are medically innocuous. Hexane, acetone, and ethanol have parts-per-million concentration limits while more dangerous solvents have parts-per-billion detection limits.

Consumers may not recognize or be aware of the fact that heavy metals such as arsenic, mercury lead, cadmium, and chromium can enter cannabis plants from polluted soils and the plants can become contaminated with microorganisms such as mold, mildew, bacteria, and yeast during the growth stage or during storage. Pathogenic bacteria and fungal toxins such as mycotoxins and aflatoxins can cause severe illness in children or immuno-compromised patients who are taking medical cannabis.

Both California and Colorado require more sophisticated wet-lab tests for pesticides and heavy metals. Washington State also mandates that licensed testing laboratories perform potency tests, moisture analysis, foreign matter, microbial and mycotoxin screenings for extracted cannabis. In Oregon, recreational marijuana is required to be tested for potency, pesticides, water activity and moisture content. A size is 0.5% of batch weight; limited to 15 pounds while concentrates and extracts must be tested for potency, pesticides and residual solvents.

Cannabis equity and inclusion

The War on Drugs implemented by President Richard Nixon in the 1970s and reinforced by Presidents Ronald Reagan and Bill Clinton in the 1980s and 1990s, respectively. As a result, American saw increased mass incarceration for Black and Brown offenders for non-violent drug related cases including marijuana. With the ongoing legalization of marijuana, more corporate, white entities are economically benefiting becoming wealthy while Black and Brown citizens formerly incarcerated for marijuana possession and use still suffer the consequences of their crimes. Black and Brown communities were arrested and convicted at much higher rates for cannabis possession than White communities with similar or higher rates of cannabis use. Some cities, recognizing the disparities, are developing initiatives to have more Black and Brown business owners and representatives of the cannabis industry.  Women owned businesses area also adversely affected by racial and gender bias in the industry.

The Department of Cannabis Regulation (DCR) in Los Angeles, California administers and processes the applications for the commercial cannabis licensing and regulatory program.

Cat Packer, Esquire was the first Executive Director of DCR where she advised the City of Los Angeles on cannabis law, policy and regulation and overseeing aw the City’s licensed commercial cannabis market. As a Black woman and a member of the who is LBGTQ community, Packer she was selected to guarantee that the communities hit hardest by the criminalization of marijuana would gain financial benefit from its legalization.

In the L.A. Times, Packer reflected on her tenure wishing she could by stating she should have better managed expectations about the cannabis licensing program that was a slow implementation process and did not doesn't guarantee licenses to all who applied for everyone. The problems, she explained, were rooted in decisions made before she was even appointed. Corey Barnette of District Growers LLC, in D.C., LLC is a licensed medical cannabis cultivation center in Washington D.C. providing cannabis flowers and edible products to dispensaries licensed in the Washington D.C. Medical Marijuana Program. He believed that some of the issues with getting diversity and growth in the cannabis market are associated with getting elected officials who do to not fear supporting Black entrepreneurship and other minority businesses in cannabis and collaboration of minority businesses into the cannabis market. Both scenarios show how structural issues and inclusion in policy needs to be addressed for cannabis markets to grow and diversify become a diverse market.

Women owned businesses area also adversely affected by racial and gender bias in the industry.

Women in cannabis testing

When cannabis began being started becoming legalized, women took began to take advantage of the emerging cannabis market.

In 2015, 36 percent of cannabis executives were women, a percentage that has substantially to just 17%  of executives. Still, although women-owned cannabis businesses make about three times as much as male-led businesses that successfully raise capital. Gender has been a significant factor in policy decisions and organizational success due to anecdotal research showing an increase in women’s  influence on the cannabis market.

Although women are increasing as consumers of cannabis, only 4.7% of cannabis businesses are owned by women in the state of Massachusetts compared to 19.3% of businesses in other industries.

In Maryland, all fifteen initial licenses for cultivation were awarded to non- minority businesses. Currently, 15.3% of all cultivation licenses held by racial and ethnic minority owners and 23.1% of cultivation license holders are women.

Women are increasingly in positions of leadership concerning using cannabis product safety.s. Rowshan Reordan, is Chief Executive Officer at Green Leaf Labs, one of the first women owned cannabis analysis labs in the U.S. and the first in Oregon.

New resources

https://www.phoenixnewtimes.com/marijuana/one-year-in-hows-arizonas-cannabis-testing-program-doing-12068021

https://www.forbes.com/sites/chrisroberts/2021/09/21/lawsuit-millions-of-pounds-of-legal-california-marijuana-is-sold-on-illegal-market/?sh=27b45fa55745

For further study on WP

1. Wikipedia:Articles for improvement
2. Wikipedia:Manual of Style/Medicine-related articles
3. Wiki Books: https://en.wikibooks.org/wiki/Feminism/Tori_Amos
4. I aspire to be on the WM Board of Trustees. Will run in 2023-24 as a community-nominated member from NYC Wikimedia Chapter. https://meta.wikimedia.org/wiki/Wikimedia_Foundation_Board_of_Trustees. ask Esra'a El Shafei about this.
   1. Wikipedia:The duck test
   2. https://discord.com/channels/819432579013935125/819442859761467392

Build protections against oversight by regulators. Situate an equitable status

1. Cannabis product testing
2. Wikipedia:Manual of Style/Medicine-related articles
3. See Food Safety and other disaggrations under "food safety"
4. FDA https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd
5. Cannabis v. Hemp industry (monetized and pushing back on public health; don't want testing at all)
6. Analytics and Analytical testing of CBD vs. Hemp
7. Instigation of public testing originaed in oregan
8. First women owned certified business in CBD testing, really not women owned. We can call those out. Minority owned businesses. RR took all the risks and opened the door.
9. Fought for public health and safety testing for years.
10. The field is being flooded like the new gold rush
11. Our largest cash crop , California has huge production
12. White male owned get VC capital.
13. Cannabis product testing
14. See Cannabis portal
15. 2020 New Zealand cannabis referendum
16. Category:2020 cannabis law reform
17. Women in the cannabis industry
18. https://www.sciencedirect.com/science/article/pii/S0166526X20300404
19. https://www.fda.gov/news-events/fda-voices/better-data-better-understanding-use-and-safety-profile-cannabidiol-cbd-products
20. Cannabis and Cannabinoid Research VOL. 5, NO. 4 | Perspective normal Labeling of Cannabidiol Products: A Public Health Perspective https://www.liebertpub.com/doi/10.1089/can.2019.0101
21. WHO https://www.who.int/medicines/access/controlled-substances/CannabidiolCriticalReview.pdf
22. Crackdown in 2019 https://www.jdsupra.com/legalnews/ftc-s-cbd-crackdown-something-old-and-92464/
23. https://www.prnewswire.com/news-releases/global-cbd-industry-projected-to-accelerate-to-23-6-billion-over-the-next-five-years-301179412.html'
24. https://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2015/01/23/10/17/regulating-commercially-legalized-marijuana-as-a-public-health-priority
25. https://www.fairwarning.org/2020/10/cannabis-patchwork-of-safety-standards/

Resources;

Victor Navone or Alien Song

Born November 2, 1970 in San Diego.

Alien Song was an early viral hit via email.

I began teaching myself character animation on my spare time, because it looked like fun and the software was becoming cheaper and more accessible.  I was inspired by the movies Toy Story and A Bug's Life, and more importantly by all the other amateur animators I was starting to see on the internet.  I grabbed a copy of Animation: Master and started reading and researching everything I could about animation and doing test exercises.  My third animation test, a lip-synch test called "Alien Song", became a viral hit on the internet.

In December of 1999 I was contacted by Pixar Animation Studios (the president had received a copy of "Alien Song" by email) and I have worked there ever since March of 2000.  “Monsters, Inc.” was my first feature project at the studio and I have worked on almost every Pixar feature film since then, including “Finding Nemo,” “The Incredibles,” “Cars,” “WALL•E,” (for which I won an award from the Visual Effects Society) “Toy Story 3,” “Cars 2,” (for which I was a Directing Animator) “Brave,” and "Monsters University".

He is cited several times under notable articles including for a handful of major awards for editing.

Category:Producers

Dan Burrus

1. TO DO
   1. Converting the red link for the Anticipatory Business Model into an article.
   2. Expanding the Hard Trend™ Methodology and Anticipatory Business Model sections in the Burrus WP article. Based on online reviews or blogs like here and here.
   3. Search for other examples to cite for the mainspace of that article.
   4. Developing an article on the Anticipatory Organization Model concept based on citations on Google Scholar and the book itself
      1. Find 3 citations in reputable sources make a case for notability on WP.
      2. Reference reviews here and here and here and here.
      3. Search for other book reviews to cite and incorporate.
      4. Embed Daniel Burrus and "Anticipatory Business Model" into the strategic planning WP article.
      5. Create a book article for The Anticipatory Organization book
2. Anticipatory Organization Method (stub article)
   1. Verify, define, detail the problem, give solution or alternative to the problem
      1. Generate all possible solutions
      2. Generate objective assessment criteria
      3. Choose the best solution generated
      4. Implement the preferred alternative
      5. Monitor and evaluate outcomes and results
   2. Requirements and limitation

The Anticipatory Organization (book)

References: Noteworthy citations and sources.

http://www.businessworld.in/article/Book-Review-The-Anticipatory-Organization-Turn-Disruption-and-Change-into-Opportunity-and-Advantage/20-03-2018-144042/

New book cites Burrus: 60 Leaders on Innovation